| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1914* | 2021 |
| UK controlled trial of intrapleural streptokinase for pleural infection NA Maskell, CWH Davies, AJ Nunn, EL Hedley, FV Gleeson, R Miller, ... New England Journal of Medicine 352 (9), 865-874, 2005 | 977 | 2005 |
| Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010 C Hooper, YCG Lee, N Maskell Thorax 65 (Suppl 2), ii4-ii17, 2010 | 955 | 2010 |
| Intrapleural use of tissue plasminogen activator and DNase in pleural infection NM Rahman, NA Maskell, A West, R Teoh, A Arnold, C Mackinlay, ... New England Journal of Medicine 365 (6), 518-526, 2011 | 831 | 2011 |
| Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ... Thorax 76 (4), 399-401, 2021 | 719 | 2021 |
| BTS guidelines for the investigation of a unilateral pleural effusion in adults N Maskell, R Butland Thorax 58 (Suppl 2), ii8, 2003 | 579 | 2003 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 541 | 2021 |
| Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial NA Maskell, FV Gleeson, RJO Davies The Lancet 361 (9366), 1326-1330, 2003 | 507 | 2003 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 462* | 2021 |
| Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score AO Clive, BC Kahan, CE Hooper, R Bhatnagar, AJ Morley, ... Thorax 69 (12), 1098-1104, 2014 | 435 | 2014 |
| A randomized controlled trial of adaptive ventilation for Cheyne–Stokes breathing in heart failure JCT Pepperell, NA Maskell, DR Jones, BA Langford-Wiley, N Crosthwaite, ... American journal of respiratory and critical care medicine 168 (9), 1109-1114, 2003 | 434 | 2003 |
| Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline DJ Feller-Kopman, CB Reddy, MM DeCamp, RL Diekemper, MK Gould, ... American journal of respiratory and critical care medicine 198 (7), 839-849, 2018 | 426 | 2018 |
| The bacteriology of pleural infection by genetic and standard methods and its mortality significance NA Maskell, S Batt, EL Hedley, CWH Davies, SH Gillespie, RJO Davies American journal of respiratory and critical care medicine 174 (7), 817-823, 2006 | 421 | 2006 |
| ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax JM Tschopp, O Bintcliffe, P Astoul, E Canalis, P Driesen, J Janssen, ... European Respiratory Journal 46 (2), 321-335, 2015 | 389 | 2015 |
| Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment AC Bibby, S Tsim, N Kanellakis, H Ball, DC Talbot, KG Blyth, NA Maskell, ... European Respiratory Review 25 (142), 472-486, 2016 | 350 | 2016 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 346 | 2022 |
| ERS/EACTS statement on the management of malignant pleural effusions AC Bibby, P Dorn, I Psallidas, JM Porcel, J Janssen, M Froudarakis, ... European journal of cardio-thoracic surgery 55 (1), 116-132, 2019 | 342 | 2019 |
| Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size NA Maskell, YCG Lee, FV Gleeson, EL Hedley, G Pengelly, RJO Davies American journal of respiratory and critical care medicine 170 (4), 377-382, 2004 | 300 | 2004 |
| The relationship between chest tube size and clinical outcome in pleural infection NM Rahman, NA Maskell, CWH Davies, EL Hedley, AJ Nunn, FV Gleeson, ... Chest 137 (3), 536-543, 2010 | 274 | 2010 |
| Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists YCG Lee, MH Baumann, NA Maskell, GW Waterer, TE Eaton, RJO Davies, ... Chest 124 (6), 2229-2238, 2003 | 268 | 2003 |
